The Effect of the Mobile Application Developed for Hemodialysis Patients on Symptoms and Disease Compliance
NCT ID: NCT05322291
Last Updated: 2022-12-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
68 participants
INTERVENTIONAL
2022-03-28
2022-07-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental Group
The developed mobile application will be installed on the phones of hemodialysis patients in the experimental group. Online consultancy and training will be provided with the application.
Mobil Application
The mobile application developed will be installed on the phones of hemodialysis patients
Control Group
No intervention will be made. They will continue to receive routine care.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Mobil Application
The mobile application developed will be installed on the phones of hemodialysis patients
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Agreeing to be a voluntary participant,
* Receiving dialysis treatment for at least 3 months,
* 18 years and over,
* Able to understand and speak Turkish
* At least primary school graduate,
* Using a smart phone for at least one year,
* Having internet access at home or at work.
* Able to use internet
Exclusion Criteria
* Having any psychiatric diagnosis or treatment that may interfere with perception (Alzheimer, schizophrenia, major depression)
* rheumatological diseases, fracture, joint health problem, amputation
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ataturk University
OTHER
Ozge AKBABA
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ozge AKBABA
PhD Student
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Erzincan Binali Yıldırım University
Erzincan, Merkez, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
OAKBABA
Identifier Type: -
Identifier Source: org_study_id